Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of Yi Cheng being referenced
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
2019
β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Yi Cheng | 31 | 380 | 119 | 256 | 236 | 34 | 1.4k | |
| Di Lü | 4 | 771 | 178 | 287 | 284 | 66 | 2.2k | |
| Lingli Yang | 3 | 310 | 90 | 143 | 263 | 53 | 1.3k | |
| Wende R. Reenstra | 3 | 268 | 135 | 109 | 634 | 34 | 1.5k | |
| Laura Cristina Ceafalan | 3 | 649 | 81 | 94 | 138 | 39 | 1.4k | |
| Mingzi Zhang | 6 | 330 | 82 | 130 | 87 | 97 | 1.3k | |
| Stephan Schäfer | 3 | 1208 | 66 | 203 | 174 | 50 | 2.2k | |
| Sarthak Sinha | 7 | 651 | 149 | 88 | 315 | 51 | 1.9k | |
| Young Hyun Jung | 5 | 750 | 262 | 94 | 212 | 58 | 1.6k | |
| John Gaffney | 1 | 944 | 156 | 312 | 139 | 35 | 1.9k | |
| Yu Chen | 8 | 561 | 84 | 88 | 281 | 62 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...